Last 15 quarters of trend data · Healthcare · Biotechnology
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
CDT Equity Inc.'s quarterly P/E stands at 0.3x, down 99.9% year-over-year — suggesting improving earnings relative to price.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.03 | 0.35 | 3.76 | — | — | 289.38 | — | 100.92 | — | 17910.00 | — | — | — |
| — | -99.9% | — | — | — | -98.4% | — | — | — | — | — | — | — | |
| P/S Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | — | 52.22 | 261.16 | 81.17 | — | — | — | — | — | — | 272.61 | 262.97 | — |
| — | — | — | — | — | — | — | — | — | — | -31.0% | +701.8% | — | |
| P/FCF | — | 0.85 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | 14255.72 | 11279.50 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | 14255.72 | 11279.50 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | -182.3% | -194.0% | -176.9% | — | — | — | — | — | 32.9% | -10.1% | -45.8% | -5.0% |
| — | — | — | — | — | — | — | — | — | +4636.0% | -11188.6% | -19586.4% | — | |
| ROA | -311.9% | -86.1% | -78.7% | -82.6% | -67.0% | -205.2% | -130.9% | -58.8% | 18.5% | 14.7% | -7.3% | -13.9% | -4.5% |
| — | +58.1% | +39.9% | -40.3% | -462.1% | -1495.7% | -1700.6% | -321.7% | +512.0% | +2201.6% | -8345.9% | -6102.1% | — | |
| ROIC | — | -230.4% | -130.6% | -153.5% | — | — | — | — | — | -7.4% | -3.8% | -23.9% | -2.0% |
| — | — | — | — | — | — | — | — | — | -1277.5% | -2270.1% | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 1326.0% YoY to 1.66x, strengthening the short-term liquidity position. Debt/Equity has declined for 3 consecutive quarters, reflecting a deleveraging trend.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | 0.44 | 0.59 | 1.07 | — | — | — | — | — | — | 0.04 | 0.02 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | 0.52 | 0.37 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.25 | 1.66 | 1.45 | 1.31 | 111.37 | 0.12 | 0.19 | 1.59 | 3.18 | 2.27 | 0.17 | 0.16 | — |
| — | +1326.0% | +676.8% | -17.8% | +3398.7% | -94.9% | +6.5% | +904.5% | — | -37.4% | -98.2% | -99.1% | — | |
| Quick Ratio | 0.25 | 1.66 | 1.45 | -80.72 | 79.43 | 0.12 | -43.45 | 1.59 | 3.18 | 2.27 | 0.17 | 0.16 | — |
| — | +1326.0% | +103.3% | -5174.2% | +2395.2% | -94.9% | -24942.9% | +904.5% | — | -37.4% | -98.2% | -99.1% | — | |
| Interest Coverage | -10.24 | -146.52 | -86.88 | -20.55 | -3.66 | -18.75 | -26.39 | -24.83 | -2.71 | -9.15 | -22.77 | -303.00 | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 15 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonCDT Equity Inc.'s current P/E is -0.0x. The average P/E over the last 2 quarters is 2.1x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking CDT Equity Inc.'s business trajectory between earnings reports.